India's drug regulator has granted restricted emergency use authorisation to Serum Institute's COVID-19 vaccine Covovax for the 12-17 years age group subject to certain conditions. IMAGE: A......
Serum Institute has the capacity to make 250 million doses of Covishield monthly. IMAGE: The Serum Institute of India has the capacity to make 250 million doses of Covishield monthly. Photograph:......
Serum Institute of India -- the maker of the most used COVID-19 vaccine in the country -- on Wednesday announced a cut in price of the jab it plans to sell to states to Rs 300 per dose from the......
Adar Poonawalla, CEO of vaccine major Serum Institute of India, on Sunday urged other countries to be patient as they wait for the supplies of COVID-19 vaccine, Covishield, as the company has been......
Five men died after a fire broke out in a five-storeyed under-construction building in the Serum Institute of India's Manjri premises in Pune on Thursday, police said. IMAGE: Smoke billows......